JMP Securities Reiterates Market Outperform on Precigen, Maintains $14 Price Target
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst Jason Butler has reiterated a Market Outperform rating on Precigen (NASDAQ:PGEN) and maintained a $14 price target.
June 04, 2024 | 12:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JMP Securities analyst Jason Butler has reiterated a Market Outperform rating on Precigen and maintained a $14 price target.
The reiteration of a Market Outperform rating and a maintained price target of $14 by JMP Securities is a positive signal for investors, likely boosting short-term confidence and potentially driving the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100